Joe Pancini
Analyst, H.C. Wainwright
Replay available
Lineage Cell Therapeutics, Inc. (AMEX: LCTX) Q1 2026 earnings conference call, held 2026-05-12. Replay captured from the company's public earnings webcast.

Analyst, H.C. Wainwright
Analyst, BYD Securities
Head of Investor Relations
Chief Financial Officer
Analyst, Raymond James
Analyst, Baird
Chief Executive Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Lineage Cell Therapeutics, Inc..
WEBVTT 00:00:00.031 -- 00:00:06.101 Welcome to the Lineage Cell Therapeutics First Quarter 2026 Conference Call. 00:00:06.101 -- 00:00:09.987 At this time, all participants are in a listen-only mode. 00:00:09.987 -- 00:00:15.015 An audio webcast of this call is available on the Investor Sections of Lineage 00:00:15.015 -- 00:00:18.016 website at www.lineagecell.com. 00:00:20.163 -- 00:00:25.792 This call is subject to copyright and is the property of Lineage, and recordings, reproductions, 00:00:25.792 -- 00:00:30.889 or transmissions of this call without the express written consent of lineage 00:00:30.889 -- 00:00:36.117 are strictly prohibited. As a reminder, today's call is being recorded. 00:00:36.117 -- 00:00:41.204 I would now like to introduce your host for today's call, Ioana Hohn, Head 00:00:41.204 -- 00:00:45.410 of Investor Relations at Lineage. Ms. Hohn, please go ahead. 00:00:45.410 -- 00:00:49.643 Thank you, Demi. Good afternoon and thank you for joining us. 00:00:49.643 -- 00:00:54.652 A press release reporting our first quarter 2026 financial results was 00:00:54.652 -- 00:00:59.741 issued earlier today, May 12th, 2026, and can be found on the investor 00:00:59.741 -- 00:01:05.332 section of our website. Please note that today's remarks and responses to your questions 00:01:05.332 -- 00:01:10.521 reflect management's views as of today only and will contain forward-looking statements 00:01:10.521 -- 00:01:13.302 within the meaning of federal securities laws. 00:01:13.302 -- 00:01:17.887 Statements made during this discussion that are not statements of historical fact should 00:01:17.887 -- 00:01:22.252 be considered forward-looking statements, which are subject to significant risks and 00:01:22.252 -- 00:01:27.458 uncertainties. The company's actual re...